Results 61 to 70 of about 479,340 (207)

Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. [PDF]

open access: yes, 2012
The level of endemicity of hepatitis B virus (HBV) infections in Italy is low and genotype D infections predominant. New HBV strains may however be introduced as a result of movements of people from regions of high endemicity.
Cacopardo B   +8 more
core   +1 more source

Hepatitis in refugees who settle in Australia [PDF]

open access: yes, 2007
Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners.BACKGROUND The World Health Organisation estimates that 2 billion ...
Benson, J., Donohue, W.
core  

World's longest surviving liver-pancreas recipient [PDF]

open access: yes, 2007
In July 1988, the liver and pancreas of a cadaveric donor were transplanted separately into a man with type 1 diabetes with end-stage chronic hepatitis B virus.
Alessiani   +20 more
core   +1 more source

The possible impact of sortilin in reducing HBsAg expression in chronic hepatitis B [PDF]

open access: yes, 2016
Hepatitis B virus (HBV) infection is a major global health problem. Chronically infected people are at risk for progressive hepatic fibrosis and consequent cirrhosis.
Besharat, S.   +6 more
core  

Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease [PDF]

open access: yes, 2015
Hepatitis B virus (HBV) infection is a dynamic state of interactions among HBV, hepatocytes, and the host immune system. Natural history studies of chronic hepatitis B (CHB) infection have shown an association between active viral replication and adverse
Farinati, Fabio   +5 more
core   +1 more source

METABOLIC AND CARDIOVASCULAR COMORBIDITIES IN BULGARIAN PATIENTS WITH CHRONIC VIRAL B AND C HEPATITIS [PDF]

open access: yesJournal of IMAB
Recent epidemiologic data on chronic viral B and C hepatitis in Bulgaria are limited.The evolution of these infections depends on liver complications and the presence of nonliver comorbidities.
Radoslava Tsrancheva   +10 more
doaj   +1 more source

52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic Hepatitis B [PDF]

open access: yes, 2013
Background and Aims: The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response.
Aldo Trylesinski   +41 more
core   +4 more sources

“To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana

open access: yesBMC Public Health, 2020
Background People with a condition subject to stigmatisation, such as chronic hepatitis B, face the dilemma of whether or not to disclose their status. In Ghana, 12.3% of the adult population has the hepatitis B virus (HBV). One key strategy for breaking
Charles Ampong Adjei   +3 more
doaj   +1 more source

Searching for chronic hepatitis B patients in a low prevalence area – role of racial origin [PDF]

open access: yes, 2004
Background Clinical studies for testing new drugs against hepatitis B ought to be carried out in low prevalence areas despite difficulties on patient recruitment.
Suzane Kioko Ono-Nita   +21 more
core   +1 more source

An expert consensus for the management of chronic hepatitis B in Asian Americans. [PDF]

open access: yes, 2018
BACKGROUND: Hepatitis B virus (HBV) infection is common with major clinical consequences. In Asian Americans, the HBsAg carrier rate ranges from 2% to 16% which approximates the rates from their countries of origin.
Abbas   +173 more
core   +2 more sources

Home - About - Disclaimer - Privacy